Page last updated: 2024-08-21

liriodenine and Carcinoma, Hepatocellular

liriodenine has been researched along with Carcinoma, Hepatocellular in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, ZF; Li, YL; Liang, H; Liu, YC; Qin, QP1
Chang, TT; Chen, CH; Chern, CL; Hsieh, PY; Hsieh, TJ; Hu, HS; Liu, TZ; Lu, FJ; Syu, YH; Tsao, DA1

Other Studies

2 other study(ies) available for liriodenine and Carcinoma, Hepatocellular

ArticleYear
A platinum(II) complex of liriodenine from traditional Chinese medicine (TCM): Cell cycle arrest, cell apoptosis induction and telomerase inhibition activity via G-quadruplex DNA stabilization.
    Journal of inorganic biochemistry, 2014, Volume: 137

    Topics: Apoptosis; Aporphines; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Line, Tumor; Coordination Complexes; G-Quadruplexes; Humans; Liver Neoplasms; Medicine, Chinese Traditional; Platinum; Platinum Compounds; Telomerase

2014
Liriodenine inhibits the proliferation of human hepatoma cell lines by blocking cell cycle progression and nitric oxide-mediated activation of p53 expression.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2005, Volume: 43, Issue:7

    Topics: Antimetabolites; Antineoplastic Agents, Phytogenic; Aporphines; Blotting, Western; Bromodeoxyuridine; Carcinoma, Hepatocellular; Cell Cycle; Cell Proliferation; Chromatography, Thin Layer; DNA, Neoplasm; Dose-Response Relationship, Drug; Flow Cytometry; Gene Expression; Genes, p53; Humans; Magnetic Resonance Spectroscopy; Magnoliaceae; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Tumor Cells, Cultured

2005